A trial of optimal personalised care after treatment for gynaecological cancer (TOPCAT-G): a randomised feasibility study comparing nurse-led telephone follow-up (intervention) with standard care (control)

Betsi Cadwaladr University Health Board0 个研究点目标入组 50 人开始时间: 2015年6月23日最近更新: 2022年11月7日

适应症

试验速览

•1. Female patients who have completed treatment for cervical, endometrial, epithelial ovarian, or vulvar cancer within the last 3 months in BCUHB in North Wales
•2. Patients who have completed treatment for fallopian tube and primary peritoneal carcinoma
•3. Patients will be included if they are considered fit for taking part in the trial and able to give informed consent, as assessed by the multi disciplinary team
•4. Patients may have received surgery, chemotherapy, radiotherapy or a combination of these but will not be receiving any continuing treatment that requires hospital care
•5. At the time of entry, patients in the view of their treating consultant will not have a definite need for continued hospital care

•1. Patients having had treatment for sarcoma, germ cell tumour, borderline tumours or choriocarcinoma will be excluded as these women tend to require specific and/or more intense follow up often with serial imaging or tumour markers
•2. Patients requiring ongoing treatment
•3. The study will not include patients who do not have capacity to give informed consent or who are deemed to be unable to take part in the trial (e.g., severe learning/mental disability, severe mental health problems)
•4. Patients who are not able to understand Welsh or English

发起方